TiGenix's P2P Acquisition

TiGenix raised a round of funding on January 05, 2018. Investors include Takeda Pharmaceutical.

TiGenix is a European cell therapy company with a clinical stage pipeline of adult stem cell programs and a commercialized product.…

Articles about TiGenix's P2P Acquisition: